THE Federal Government has announced August 16 as the new date for the beginning of the second phase of Covid-19 vaccination in the country.
The phase will see the country administering the Moderna vaccine doses donated by the United States.
Minister of Information and Culture, Alhaji Lai Mohammed, disclosed this today while featuring on “Good Morning Nigeria,” a live programme of the Nigerian Television Authority which was monitored by our correspondent.
The minister explained that the postponement of the commencement from August 10 to August 16 was “purely administrative.”
He said, “We have received 4,800,000 doses of the Moderna vaccine and we will commence administering the doses on Monday, August 16.
“The exercise was supposed to commence tomorrow (Tuesday), August 10, but we suspended it till Monday, and the reason is purely administrative.
“When vaccines arrive the country, they are taken to National Agency for Food and Drug Administration and Control.
“The agency will analyse them and thereafter give us a green light for the use.”
The minister debunked insinuations that the exercise was postponed indefinitely over concerned raised by some experts on the propriety of using Moderna vaccine.
He said, likethe first batch of the AstraZeneca vaccine which had been fully administered without hitch, the doses of Moderna vaccine donated to the country by the US were “safe and meant to save lives.”
He added, “I want to thank Nigerians for the way they responded to the first batch of AstraZeneca vaccine.
“I can say authoritatively that we succeeded administering the four million doses of the vaccine and we do not have a single expired vaccine. They were all administered to the targeted population.
“I want to encourage Nigerians to come out also to take the Moderna vaccine.”
The minister also disclosed that the second phase of the vaccination would target people from 18 years and above.
He explained that the 18 years and above were targeted because the younger ones, even in the US, were now becoming more vulnerable to Covid-19 infection and attack.
